Diabetes and the solid organ transplant recipient

Area of Science:

• Transplantation Medicine
• Infectious Diseases
• Immunology

Background:

• Cardiovascular risk screening significantly reduced post-transplant morbidity and mortality.
• Long-term follow-up reveals increasing pulmonary and urinary tract infections, with sepsis, as major causes of mortality.
• Infection-related endpoints now dominate all-cause mortality in transplant recipients.

Purpose of the Study:

• To review infection risks across kidney, liver, heart, and lung transplant recipients.
• To emphasize the heightened susceptibility of diabetic transplant recipients to infections.
• To discuss the implications of antibiotic resistance due to repeated antibiotic prescriptions.

Main Methods:

• Comprehensive literature review of infection risks in solid organ transplant recipients.
• Analysis of competing factors of morbidity and mortality, focusing on infection endpoints.
• Specific examination of infection risks in diabetic patient populations undergoing immunosuppression.

Main Results:

• Infection, including sepsis, is a significant competing cause of morbidity and mortality post-transplant.
• Diabetic transplant recipients exhibit a markedly increased risk for bacterial and fungal infections.
• Immunosuppression therapy exacerbates infection susceptibility in allograft recipients.

Conclusions:

• Infection has emerged as a primary driver of mortality in solid organ transplant recipients.
• Diabetic patients represent a particularly vulnerable subset requiring targeted infection prevention strategies.
• The evolution of antibiotic-resistant pathogens necessitates careful antibiotic stewardship in this population.